id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-324809-16zvqizl	Mehta, Neil	Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic	2020-07-08		.txt	text/plain	4802	213	32	Abstract The Coronavirus disease 2019 (COVID-19) pandemic is expected to have a long-lasting impact on the approach to care for patients at risk for and with hepatocellular carcinoma (HCC) due to the risks from potential exposure and resource reallocation. Existing HCC risk stratification models should be utilized to prioritize imaging resources to those patients at highest risk of incident HCC and recurrence following therapy though surveillance can likely continue as before in settings where COVID-19 prevalence is low and adequate protections are in place. COVID-related risks may be especially relevant in patients with cirrhosis and hepatocellular carcinoma (HCC), for whom management often involves multiple interactions with the healthcare system (e.g. phlebotomy, radiological imaging, clinic visits, and HCC-directed treatments) but who may be more susceptible to severe COVID-related complications. Regional COVID-19 exposure risk may impact choice of systemic therapy in advanced HCC based upon availability of local resources (e.g. infusion center, endoscopy, clinical trials) and risk of regimen-specific toxicities (e.g. immune-related adverse events which may require high doses of corticosteroids).	./cache/cord-324809-16zvqizl.txt	./txt/cord-324809-16zvqizl.txt